Noah G. Shuart
Burnaby, BC V5G4W8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Molecular Pharmacology of Selective NaV1.6 and Dual NaV1.6/NaV1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo.
Journal: ACS chemical neuroscience
Published: February 15, 2024
The contribution of NaV1.6 to the efficacy of voltage-gated sodium channel inhibitors in wild type and NaV1.6 gain-of-function (GOF) mouse seizure control.
Journal: British journal of pharmacology
Published: December 21, 2023
Expanding the genotype-phenotype spectrum in SCN8A-related disorders.
Journal: Research square
Published: August 23, 2023
Expanding the genotype-phenotype spectrum in SCN8A-related disorders.
Journal: BMC neurology
Published: July 31, 2023
Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective NaV1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy.
Journal: Journal of medicinal chemistry
Published: September 19, 2019
Inhibitory effects of cannabidiol on voltage-dependent sodium currents.
Journal: The Journal of biological chemistry
Published: July 17, 2018
Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain.
Journal: Journal of medicinal chemistry
Published: May 09, 2018
Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models.
Journal: ACS medicinal chemistry letters
Published: November 20, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026